Medtronic plc tariff impact clarified, shares stay anchored in S&P 500 context
28.06.2026 - 15:03:46 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-28, 15:03.
Medtronic plc (IE00BTN1Y115) has recently quantified the impact of U.S. tariffs on its business, a factor closely watched by investors in the New York-listed medical technology group. The S&P 500 constituent expects a reduced total tariff burden of $250 million for fiscal 2027, including $75 million in the first quarter, according to comments by Chairman and CEO Geoffrey Martha on Fox Business Network earlier in June.A June 8 summary of Martha's remarks highlights the revised tariff estimate and its timing
What the CEO now expects
On June 8, 2026, Geoffrey Martha stated that Medtronic now anticipates a $250 million tariff hit for fiscal 2027, a notable reduction from the previously signaled $300 million figure, mainly due to supply chain adjustments and sourcing changes.The televised interview recap explains that the company has shifted parts of its manufacturing and logistics footprint to mitigate tariff exposure The updated guidance includes an estimated $75 million tariff impact in the first quarter of fiscal 2027, providing a clearer quarterly phasing for analysts.
Medtronic is one of the larger medical device names on the NYSE, with a broad global supply chain spanning the United States, Europe and Asia, making trade policy a material planning variable. The reduced tariff estimate suggests some success in re-routing production or procurement, but still implies a meaningful cost headwind that must be absorbed or offset through pricing and efficiency measures.Market data providers classify Medtronic as a diversified medical technology company with a significant U.S. revenue base
How the shares are valued today
Medtronic shares trade on the NYSE under the ticker MDT and closed at $80.94 on June 26, 2026, with modest after-hours trading nudging the price to $81.06, according to recent market snapshots.The same data show a 50-day trading range between roughly $73.72 and $81.87 for the stock In euro terms, secondary price indications around €71 on European platforms underline the cross-currency valuation that some investors monitor.European quote services list Medtronic with the ISIN IE00BTN1Y115 and a recent euro price near €71
Analyst commentary in recent months has tended to focus on Medtronic's balance between slower legacy product segments and newer growth areas such as cardiac rhythm management, minimally invasive surgical tools and neuromodulation. The clarified tariff outlook adds another parameter to valuation models, particularly for houses that emphasize margin sensitivity to external cost shocks. While there is no fresh rating change tied directly to Martha's June comments, the quantified $250 million headwind is a concrete input into consensus estimates.
All news and analysis on the Medtronic plc shares
Track further tariff updates, earnings figures and valuation metrics for Medtronic plc with the latest coverage and data on the MDT listing.
The product engine behind Medtronic
Medtronic generates its revenue primarily from medical devices that support cardiovascular, diabetes and neurological care, with cardiac rhythm management systems standing out as a core franchise. A representative product line is the company’s implantable pacemakers and implantable cardioverter defibrillators, which are used worldwide to stabilize heart rhythm and prevent sudden cardiac arrest. These devices integrate hardware, software and increasingly data connectivity, positioning Medtronic in the broader trend toward digitally monitored, minimally invasive therapies.
Where the stock trades today
Medtronic plc shares (IE00BTN1Y115) most actively trade on the NYSE under the ticker MDT and last closed at $80.94 on 2026-06-26, 15:59 Eastern Time, equivalent to approximately €71 on parallel European indications.
Medtronic plc at a glance
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- WKN: A14M2J
- Ticker: MDT
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 80.94 USD
- Market cap: approximately 107 billion USD (as of 2026-06-26)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for information purposes only and does not constitute investment advice, a securities recommendation or an offer or solicitation to buy or sell any financial instrument. All data were obtained from sources believed to be reliable, but their accuracy cannot be guaranteed. Investors should conduct their own research and consider seeking independent financial advice before making investment decisions.
